chr11-17533369-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000527720.5(USH1C):​c.-104G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 1,379,894 control chromosomes in the GnomAD database, including 12,668 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 982 hom., cov: 31)
Exomes 𝑓: 0.12 ( 11686 hom. )

Consequence

USH1C
ENST00000527720.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.769

Publications

2 publications found
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
USH1C Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • autosomal recessive nonsyndromic hearing loss 18A
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-17533369-C-A is Benign according to our data. Variant chr11-17533369-C-A is described in ClinVar as Benign. ClinVar VariationId is 262735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1CNM_153676.4 linkc.37-47G>T intron_variant Intron 1 of 26 ENST00000005226.12 NP_710142.1
USH1CNM_005709.4 linkc.37-47G>T intron_variant Intron 1 of 20 ENST00000318024.9 NP_005700.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1CENST00000005226.12 linkc.37-47G>T intron_variant Intron 1 of 26 5 NM_153676.4 ENSP00000005226.7
USH1CENST00000318024.9 linkc.37-47G>T intron_variant Intron 1 of 20 1 NM_005709.4 ENSP00000317018.4

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
15345
AN:
146812
Hom.:
980
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0712
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0860
Gnomad ASJ
AF:
0.0852
Gnomad EAS
AF:
0.0637
Gnomad SAS
AF:
0.263
Gnomad FIN
AF:
0.137
Gnomad MID
AF:
0.138
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.0968
GnomAD2 exomes
AF:
0.126
AC:
29540
AN:
233934
AF XY:
0.134
show subpopulations
Gnomad AFR exome
AF:
0.0771
Gnomad AMR exome
AF:
0.0743
Gnomad ASJ exome
AF:
0.0942
Gnomad EAS exome
AF:
0.0595
Gnomad FIN exome
AF:
0.141
Gnomad NFE exome
AF:
0.120
Gnomad OTH exome
AF:
0.127
GnomAD4 exome
AF:
0.125
AC:
153849
AN:
1232970
Hom.:
11686
Cov.:
17
AF XY:
0.129
AC XY:
80407
AN XY:
625138
show subpopulations
African (AFR)
AF:
0.0625
AC:
1807
AN:
28924
American (AMR)
AF:
0.0756
AC:
3345
AN:
44268
Ashkenazi Jewish (ASJ)
AF:
0.0903
AC:
2230
AN:
24690
East Asian (EAS)
AF:
0.0580
AC:
2221
AN:
38304
South Asian (SAS)
AF:
0.265
AC:
21761
AN:
82032
European-Finnish (FIN)
AF:
0.130
AC:
6050
AN:
46664
Middle Eastern (MID)
AF:
0.111
AC:
580
AN:
5242
European-Non Finnish (NFE)
AF:
0.120
AC:
109115
AN:
910080
Other (OTH)
AF:
0.128
AC:
6740
AN:
52766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
6892
13784
20677
27569
34461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3720
7440
11160
14880
18600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15346
AN:
146924
Hom.:
982
Cov.:
31
AF XY:
0.108
AC XY:
7736
AN XY:
71818
show subpopulations
African (AFR)
AF:
0.0710
AC:
2636
AN:
37106
American (AMR)
AF:
0.0859
AC:
1290
AN:
15012
Ashkenazi Jewish (ASJ)
AF:
0.0852
AC:
295
AN:
3462
East Asian (EAS)
AF:
0.0637
AC:
327
AN:
5134
South Asian (SAS)
AF:
0.263
AC:
1257
AN:
4772
European-Finnish (FIN)
AF:
0.137
AC:
1446
AN:
10518
Middle Eastern (MID)
AF:
0.134
AC:
38
AN:
284
European-Non Finnish (NFE)
AF:
0.116
AC:
7835
AN:
67688
Other (OTH)
AF:
0.0997
AC:
203
AN:
2036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
599
1199
1798
2398
2997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0104
Hom.:
10
Bravo
AF:
0.111

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive nonsyndromic hearing loss 18A Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 1C Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.7
DANN
Benign
0.45
PhyloP100
-0.77
PromoterAI
0.028
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2355022; hg19: chr11-17554916; API